Heliox-driven β2-agonists nebulization for children and adults with acute asthma: a systematic review with meta-analysis

This review suggests that heliox benefits in airflow limitation and hospital admissions could be considered clinically significant. Data support the use of heliox as a nebulizing β2-agonist driving gas in the routine care of patients with acute asthma.